Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 5 SUPPL. 1, 2000, Pages

  Touyz, R M ^a   Turgeon, A ^a   Schiffrin, E L ^a  

^a NONE   (Canada)

Author keywords

Endothelin; Endothelin antagonists; Hypertension; Rats inbred SHRSP; Renal failure

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HYPERTENSION; KIDNEY CELL; KIDNEY DISEASE; KIDNEY FUNCTION; LIFESPAN; MALE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RAT; SALT INTAKE; SEX DIFFERENCE; STROKE; SURVIVAL TIME;

EID: 0033752086     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200036001-00057     Document Type: Article

References (24)

1. Vascular biology of endothelin
2. Endothelin: Potential role in hypertension and vascular hypertrophy. Brief review
3. Cloning and expression of a cDNA encoding an endothelin receptor
4. Antihypertensive effects of a novel endothelin A receptor antagonist in rats
5. Effect of chronic treatment of adult SHRs with an endothelin receptor antagonist
6. Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats
7. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats
8. Increased endothelin-1 content in blood vessels of DOCA-salt hypertensive rats but not in SHRs
9. DOCA plus salt induce overexpression of vascular ET-1 and severe vascular hypertrophy in SHRs
10. Vascular ET-1 gene expression and effect of an ET(A) antagonist on structure and function of small arteries from SHRSPs
11. Antihypertensive effect of bosentan, a mixed ET(A)/ET(B) endothelin receptor antagonist in DOCA-salt SHRs
12. Nephroprotection of an ET(A) receptor blocker (LU 135252) in salt-loaded uninephrectomized SHRSPs
13. ET(A) receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats
14. ET(A) receptor blockade alleviates hypertension and renal lesions associated with chronic NO synthase inhibition
15. Endothelin antagonism in end-organ damage of SHRs
16. Early-onset but not late-onset ET(A) receptor blockade can modulate hypertension, cerebral edema and proteinuria in SHRSPs
17. Enalapril prevents imminent and reduces manifest cerebral edema in SHRSPs
18. Effect of chronic ET(A)-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats
19. Integrated cardiac, renal and endocrine actions of endothelin
20. + exchange, c-fos expression, and mitogenesis in rat mesangial cells
21. Role of endothelin as a mitogen in experimental glomerulonephritis in rats
22. Involvement of Ang II and ET-1 in matrix protein production and renal sclerosis
23. ET-1 stimulates PDGF secretion in cultured human mesangial cells
24. Mechanism of progression of renal disease: Growth factors and related mechanisms